bimekizumab (UCB4940) - UCB
Bimekizumab: Topline data from P3b BE RADIANT trial (NCT03536884) for psoriasis in Q2 2020 (UCB) - Feb 21, 2020 - FY 2019 Results 
P3 data: top line
https://www.ucb.com/_up/ucb_com_ir/documents/2019%20FY%20press%20release%20-%20final.pdf
 
Feb 21, 2020
 
 
6e5d7b02-991d-4740-b1e2-08a6f9d0e90a.png